Skip to main content
. 2024 Jan 20;205(2):349–358. doi: 10.1007/s10549-023-07229-y

Table 1.

Summary of patient and tumor characteristics in the total population and by subgroup

Total population Lymph node negative Lymph node positive Age ≤ 50 years (premenopausal) Age ≥ 60 years (postmenopausal)
Median age (IQR), years 56 (49–63) 57 (50–64) 53 (47–61) 45 (41–48) 65 (62–68)
Median tumor size (IQR), cm 1.6 (1.2–2.2) 1.4 (1.1–1.9) 2.1 (1.5–2.7) 1.8 (1.4–2.5) 1.5 (1.1–2.0)
Tumor type, n (%)
 Ductal (including mixed) 681 (85.02) 464 (84.67) 217 (85.77) 215 (87.40) 247 (82.61)
 Lobular 83 (10.36) 54 (9.85) 29 (11.46) 22 (8.94) 38 (12.71)
 Mixed no special type and lobular 1 (0.12) 1 (0.18) 0 (0.00) 0 (0.00) 1 (0.33)
 Special type 35 (4.37) 29 (5.29) 6 (2.37) 8 (3.25) 13 (4.35)
 Tubular 1 (0.12) 0 (0.00) 1 (0.40) 1 (0.41) 0 (0.00)
Tumor grade, n (%)
 1 168 (20.97) 134 (24.45) 34 (13.44) 34 (13.82) 75 (25.08)
 2 395 (49.31) 267 (48.72) 128 (50.59) 106 (43.09) 148 (49.50)
 3 238 (29.71) 147 (26.82) 91 (35.97) 106 (43.09) 76 (25.42)
Lymph node status, n (%)
 Negative 548 (68.41) 548 (100.00) 0 (0.00) 148 (60.16) 226 (75.59)
 1–3 positive 253 (31.59) 0 (0.00) 253 (100.00) 98 (39.84) 73 (24.41)
Pleomorphism, n (%)
 1 17 (2.12) 14 (2.55) 3 (1.19) 3 (1.22) 9 (3.01)
 2 300 (37.45) 219 (39.96) 81 (32.02) 63 (25.61) 131 (43.81)
 3 477 (59.55) 309 (56.39) 168 (66.40) 176 (71.54) 157 (52.51)
 Missing data 7 (0.87) 6 (1.09) 1 (0.40) 4 (1.63) 2 (0.67)
Nottingham prognostic index, n (%)
 Good prognostic score 371 (46.32) 346 (63.14) 25 (9.88) 79 (32.11) 159 (53.18)
 Moderate prognostic score 371 (46.32) 202 (36.86) 169 (66.80) 138 (56.10) 125 (41.81)
 Poor prognostic score 58 (7.24) 0 (0.00) 58 (22.92) 28 (11.38) 15 (5.02)
 Missing data 1 (0.12) 0 (0.00) 1 (0.40) 1 (0.41) 0 (0.00)
Recurrence
 No 642 (80.15) 459 (83.76) 183 (72.33) 190 (77.24) 240 (80.27)
 Yes 159 (19.85) 89 (16.24) 70 (27.67) 56 (22.76) 59 (19.73)